Sign in

CIK 0001822791

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CLNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
852828339
Phone
+1 801-676-9695
Business address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
Former names
Chelsea Worldwide Inc.
  1. 4 Open-market buy Director bought 149,610 shares at an average $2.50 ($374,771)
  2. 4 Open-market sale Chief Science Officer sold 20,247 shares at $2.47 ($50,010)
  3. 4 Open-market buy Director bought 5,000 shares at $2.62 ($13,100)
  4. 4 Open-market buy Director bought 96,011 shares at $2.66 ($255,389)
  5. 4 Open-market buy Director bought 55,000 shares at $3.06 ($168,300)
  6. 4 Open-market buy Director bought 60,670 shares at an average $2.55 ($154,822)
  7. 4 Open-market buy Director bought 35,000 shares at $2.27 ($79,450)
  8. 4 Open-market sale 10% owner sold 181,818 shares at $2.20 ($400,000)
  9. 4 Open-market buy Director bought 181,818 shares at $2.20 ($400,000)
  10. 4 Open-market sale Chief Medical Officer sold 4,717 shares at $2.03 ($9,576)
  11. 4 Open-market buy Director bought 10,000 shares at $2.08 ($20,800)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Option exercise Director acquired 100,000 shares (option exercise)
  20. 4 Open-market sale 10% owner sold 132,891 shares at $3.01 ($400,002)

Page 13 of 19 · 368 filings